 |
sofosbuvir/velpatasvir |
|---|---|
| Trade Name | Epclusa |
| Orphan Indication | Pediatric chronic hepatitis C virus (HCV) infection |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-22 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 |
